When all four acetylation sites are mutated simultaneously (p53 3KR : K98R+3KR(K117R+K161R+K162R)), It entirely nullifies its capacity to modulate metabolic targets (such as TIGAR and SLC7A11), severely impairing the transcriptional activity of p53
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: the STEP 3 Randomized Clinical Trial
For some, however, the appetite suppression these medications produce can interact with pre-existing vulnerabilities around eating in ways that are worth being aware of
04 Adults Only Approved for adults with a BMI of 30 kg/m or higher, or a BMI of 27 kg/m or higher with at least one weight-related comorbidity
You might need to up your exercise routine
So, for some people, semaglutide doesnt lead to clinically meaningful weight loss for those considered non-responders